Masimo ROA 2007-2019 | MASI

Current and historical return on assets (ROA) values for Masimo (MASI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Masimo ROA for the three months ending March 31, 2019 was 15.57%.
Masimo ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-03-31 $0.20B $1.18B 17.76%
2018-12-31 $0.19B $1.16B 18.44%
2018-09-30 $0.14B $1.10B 14.05%
2018-06-30 $0.12B $1.01B 12.53%
2018-03-31 $0.12B $0.95B 13.02%
2017-12-31 $0.13B $0.91B 13.95%
2017-09-30 $0.36B $0.91B 41.02%
2017-06-30 $0.35B $0.90B 43.41%
2017-03-31 $0.34B $0.88B 45.70%
2016-12-31 $0.31B $0.82B 46.50%
2016-09-30 $0.11B $0.64B 17.85%
2016-06-30 $0.10B $0.60B 16.81%
2016-03-31 $0.09B $0.62B 15.09%
2015-12-31 $0.08B $0.60B 14.19%
2015-09-30 $0.08B $0.58B 13.90%
2015-06-30 $0.08B $0.58B 13.48%
2015-03-31 $0.07B $0.58B 13.08%
2014-12-31 $0.07B $0.57B 14.21%
2014-09-30 $0.06B $0.53B 12.65%
2014-06-30 $0.06B $0.50B 13.59%
2014-03-31 $0.07B $0.46B 15.09%
2013-12-31 $0.06B $0.44B 14.04%
2013-09-30 $0.06B $0.43B 16.12%
2013-06-30 $0.06B $0.40B 15.80%
2013-03-31 $0.06B $0.39B 16.22%
2012-12-31 $0.06B $0.38B 16.30%
2012-09-30 $0.06B $0.41B 16.14%
2012-06-30 $0.06B $0.38B 16.79%
2012-03-31 $0.06B $0.38B 16.85%
2011-12-31 $0.06B $0.37B 18.03%
2011-09-30 $0.07B $0.37B 19.35%
2011-06-30 $0.07B $0.35B 20.35%
2011-03-31 $0.06B $0.33B 20.22%
2010-12-31 $0.07B $0.31B 23.76%
2010-09-30 $0.07B $0.33B 22.27%
2010-06-30 $0.07B $0.30B 21.18%
2010-03-31 $0.07B $0.29B 20.63%
2009-12-31 $0.05B $0.36B 16.15%
2009-09-30 $0.04B $0.34B 12.16%
2009-06-30 $0.04B $0.32B 12.83%
2009-03-31 $0.04B $0.31B 12.86%
2008-12-31 $0.03B $0.29B 12.28%
2008-09-30 $0.04B $0.27B 17.87%
2008-06-30 $0.04B $0.25B 16.19%
2008-03-31 $0.03B $0.23B 13.92%
2007-12-31 $0.02B $0.24B 14.49%
2007-09-30 $0.02B $0.23B 15.04%
2007-06-30 $0.01B $0.17B 27.59%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $8.237B $0.858B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $115.527B 25.27
Intuitive Surgical (ISRG) United States $60.928B 56.14
Edwards Lifesciences (EW) United States $39.801B 39.77
IDEXX Laboratories (IDXX) United States $24.444B 64.13
Fresenius Medical Care AG KGaA (FMS) Germany $24.394B 16.03
Teleflex (TFX) United States $15.460B 33.50
Olympus (OCPNY) Japan $15.407B 115.28
SONOVA HOLDING (SONVY) Switzerland $14.561B 0.00
Sysmex ADR (SSMXY) Japan $14.417B 38.87
DexCom (DXCM) United States $13.759B 269.84
Hologic (HOLX) United States $12.689B 20.41
STERIS (STE) Ireland $12.575B 30.42
Varian Medical Systems (VAR) United States $12.300B 31.38
ABIOMED (ABMD) United States $11.800B 71.79
Penumbra (PEN) United States $6.000B 254.01
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.153B 38.83
Integra LifeSciences Holdings (IART) United States $4.599B 21.61
Globus Medical (GMED) United States $4.096B 25.54
Tandem Diabetes Care (TNDM) United States $3.740B 0.00
LivaNova (LIVN) United Kingdom $3.605B 23.50
Wright Medical Group (WMGI) Netherlands $3.365B 667.00
Cantel Medical (CMD) United States $3.364B 34.13
Glaukos (GKOS) United States $2.750B 0.00
Integer Holdings (ITGR) United States $2.675B 19.71
Nihon Kohden (NHNKY) Japan $2.449B 24.64
AVANOS MEDICAL, INC (AVNS) United States $2.029B 32.12
Nevro (NVRO) United States $1.983B 0.00
Inogen (INGN) United States $1.373B 30.40
OPKO Health (OPK) United States $1.317B 0.00
Silk Road Medical (SILK) United States $1.239B 0.00
Veracyte (VCYT) United States $1.167B 0.00
CryoLife (CRY) United States $1.116B 110.70
Accelerate Diagnostics (AXDX) United States $1.055B 0.00
Tactile Systems Technology (TCMD) United States $1.032B 152.33
ORTHOFIX MEDICAL INC (OFIX) United States $0.983B 28.48
Mesa Laboratories (MLAB) United States $0.912B 42.88
Pacific Biosciences Of California (PACB) United States $0.910B 0.00
ViewRay (VRAY) United States $0.907B 0.00
Luminex (LMNX) United States $0.882B 115.35
Natus Medical (BABY) United States $0.880B 20.37
AngioDynamics (ANGO) United States $0.810B 26.55
AxoGen (AXGN) United States $0.767B 0.00
Fluidigm (FLDM) United States $0.759B 0.00
Quotient (QTNT) Switzerland $0.696B 0.00
Intersect ENT (XENT) United States $0.651B 0.00
Corindus Vascular Robotics (CVRS) United States $0.581B 0.00
OrthoPediatrics (KIDS) United States $0.541B 0.00
Si-Bone (SIBN) United States $0.483B 0.00
GenMark Diagnostics (GNMK) United States $0.361B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.354B 18.99
RTI Surgical (RTIX) United States $0.312B 38.36
Accuray (ARAY) United States $0.309B 0.00
TransEnterix (TRXC) United States $0.304B 0.00
Semler Scientific (SMLR) United States $0.289B 57.37
SeaSpine Holdings (SPNE) United States $0.245B 0.00
Neuronetics (STIM) United States $0.235B 0.00
ConforMIS (CFMS) United States $0.231B 0.00
Alphatec Holdings (ATEC) United States $0.208B 0.00
IRadimed (IRMD) United States $0.203B 38.64
CRH Medical (CRHM) Canada $0.201B 69.75
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.172B 0.00
Second Sight Medical Products (EYES) United States $0.100B 0.00
Ekso Bionics Holdings (EKSO) United States $0.093B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
Vermillion (VRML) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
T2 Biosystems (TTOO) United States $0.069B 0.00
Apollo Endosurgery (APEN) United States $0.066B 0.00
Spectral Diagnostics (EDTXF) Canada $0.066B 0.00
Helius Medical Technologies (HSDT) United States $0.053B 0.00